|Barry Buckland, Ph.D.|
Chairman, Scientific Adivsory Board, Enumeral
Chief Executive Officer, BiologicB
Dr. Buckland has been a member of our Board of Directors since 2009. His career in the pharmaceutical industry includes leadership of Merck’s world class Bioprocess Research and Development Group which saw the market launch of major biological products, including Gardasil®, Rotateq®, and Zostavax®. Dr. Buckland has been the Chief Executive Officer of BiologicB, a consulting firm working with biotechnology and vaccine products, since 2009. He is the recipient of numerous awards, among them the Donald Medal, UK Institute of Chemical Engineering in 2002, Prix Galien award as a member of the team that received the Vaccine Award for Gardasil in 2007, the Marvin Johnson award by ACS for lifetime contribution to Biotechnology in 2008, and the PhRMA Discoverer of the Year for development of the Merck HPV vaccine (along with Eliav Barr and Kathrin Jansen) in 2009. Dr. Buckland has chaired multiple International Conferences related to bioprocess research and development and vaccine technology and is an author on over 70 papers. He has been a Visiting Professor at University College London since 1995. Dr. Buckland earned his Ph.D. in biochemical engineering at University College London.